Sten Verland
Venture Partner (founding partner)
Sunstone Life Science VenturesCopenhagen, Capital Region of Denmark, Denmark
10 investmentsSten Verland is a Venture Partner (founding partner) at Sunstone Life Science Ventures based in Copenhagen, Capital Region of Denmark, Denmark. Sten Verland has backed 10 companies, including Minervax ApS, Glycom A/S and F2G LTD. Investment focus areas include Health Care, Wellness and Investment Management.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Health Care
Wellness
Investment Management
Strategic Partnerships
Life Science
Engineering
Portfolio Management
Medical Technologies
Business Development
Biotechnology
Drug Development
Innovation
Clinical Trials
Mergers and Acquisitions
Medical
B2B
Therapeutics
Media and Entertainment
Pharmaceuticals
Risk Management
Acquisitions
Oncology
Portfolio Companies (10)
| 1 | Minervax ApS |
| 2 | Glycom A/S |
| 3 | F2G LTD |
| 4 | Rigontec GmbH |
| 5 | Orphazyme A/S |
| 6 | NsGene A/S |
| 7 | Action Pharma A/S |
| 8 | Vaximm AG |
| 9 | Proxi Biotech |
| 10 | Zymenex |
Showing 1–10 of 10
Access Full Contact Information
Get Sten Verland's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.